KR100338399B1 - 미백제로서의 광 미백제를 함유하는 피부 미백용 조성물 - Google Patents
미백제로서의 광 미백제를 함유하는 피부 미백용 조성물 Download PDFInfo
- Publication number
- KR100338399B1 KR100338399B1 KR1019990016621A KR19990016621A KR100338399B1 KR 100338399 B1 KR100338399 B1 KR 100338399B1 KR 1019990016621 A KR1019990016621 A KR 1019990016621A KR 19990016621 A KR19990016621 A KR 19990016621A KR 100338399 B1 KR100338399 B1 KR 100338399B1
- Authority
- KR
- South Korea
- Prior art keywords
- composition
- skin
- agent
- whitening agent
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 118
- 238000004061 bleaching Methods 0.000 title claims 3
- 230000003287 optical effect Effects 0.000 title claims 2
- 239000007844 bleaching agent Substances 0.000 title description 12
- 230000002087 whitening effect Effects 0.000 claims abstract description 50
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 41
- 150000001875 compounds Chemical class 0.000 claims abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 10
- 239000007854 depigmenting agent Substances 0.000 claims abstract description 6
- 230000001153 anti-wrinkle effect Effects 0.000 claims abstract description 5
- NSMMFSKPGXCMOE-UHFFFAOYSA-N 2-[2-(2-sulfophenyl)ethenyl]benzenesulfonic acid Chemical compound OS(=O)(=O)C1=CC=CC=C1C=CC1=CC=CC=C1S(O)(=O)=O NSMMFSKPGXCMOE-UHFFFAOYSA-N 0.000 claims description 11
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 11
- 239000011734 sodium Substances 0.000 claims description 11
- 229910052708 sodium Inorganic materials 0.000 claims description 11
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N 1,4-Benzenediol Natural products OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims description 9
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 9
- 230000000903 blocking effect Effects 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 6
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims description 6
- BDJRBEYXGGNYIS-UHFFFAOYSA-N nonanedioic acid Chemical compound OC(=O)CCCCCCCC(O)=O BDJRBEYXGGNYIS-UHFFFAOYSA-N 0.000 claims description 6
- 230000005855 radiation Effects 0.000 claims description 6
- 229920006395 saturated elastomer Polymers 0.000 claims description 6
- AIXZBGVLNVRQSS-UHFFFAOYSA-N 5-tert-butyl-2-[5-(5-tert-butyl-1,3-benzoxazol-2-yl)thiophen-2-yl]-1,3-benzoxazole Chemical compound CC(C)(C)C1=CC=C2OC(C3=CC=C(S3)C=3OC4=CC=C(C=C4N=3)C(C)(C)C)=NC2=C1 AIXZBGVLNVRQSS-UHFFFAOYSA-N 0.000 claims description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 4
- 239000004202 carbamide Substances 0.000 claims description 4
- 125000004122 cyclic group Chemical group 0.000 claims description 4
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 claims description 4
- 229960004705 kojic acid Drugs 0.000 claims description 4
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 claims description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 4
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical class NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims description 3
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 3
- 229960000271 arbutin Drugs 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims description 3
- 125000000565 sulfonamide group Chemical group 0.000 claims description 3
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 claims description 2
- 125000000217 alkyl group Chemical group 0.000 claims description 2
- 239000003410 keratolytic agent Substances 0.000 claims description 2
- 235000014655 lactic acid Nutrition 0.000 claims description 2
- 239000004310 lactic acid Substances 0.000 claims description 2
- 229960005489 paracetamol Drugs 0.000 claims description 2
- 150000003839 salts Chemical class 0.000 claims description 2
- MXJGWNPVKBVVTM-UHFFFAOYSA-N 5-tert-butyl-1,3-benzoxazole Chemical compound CC(C)(C)C1=CC=C2OC=NC2=C1 MXJGWNPVKBVVTM-UHFFFAOYSA-N 0.000 claims 7
- 239000003906 humectant Substances 0.000 claims 1
- 125000000687 hydroquinonyl group Chemical group C1(O)=C(C=C(O)C=C1)* 0.000 claims 1
- 239000002537 cosmetic Substances 0.000 abstract description 24
- 238000002360 preparation method Methods 0.000 abstract description 8
- 239000004909 Moisturizer Substances 0.000 abstract description 3
- 230000001333 moisturizer Effects 0.000 abstract description 3
- 230000000699 topical effect Effects 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 28
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 7
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000006071 cream Substances 0.000 description 6
- 239000003995 emulsifying agent Substances 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 5
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 5
- YGUMVDWOQQJBGA-VAWYXSNFSA-N 5-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-[(e)-2-[4-[(4-anilino-6-morpholin-4-yl-1,3,5-triazin-2-yl)amino]-2-sulfophenyl]ethenyl]benzenesulfonic acid Chemical compound C=1C=C(\C=C\C=2C(=CC(NC=3N=C(N=C(NC=4C=CC=CC=4)N=3)N3CCOCC3)=CC=2)S(O)(=O)=O)C(S(=O)(=O)O)=CC=1NC(N=C(N=1)N2CCOCC2)=NC=1NC1=CC=CC=C1 YGUMVDWOQQJBGA-VAWYXSNFSA-N 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000013877 carbamide Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000000945 filler Substances 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 3
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 3
- 239000012071 phase Substances 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 239000008117 stearic acid Substances 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical class C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 2
- PDNLXUROKBBMBE-BYOHNYAZSA-N (Z)-octadec-9-enoic acid (3R,4S,5R,6R)-3,4,5,6,7-pentahydroxyheptan-2-one Chemical compound CC(=O)[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O PDNLXUROKBBMBE-BYOHNYAZSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- IXIGWKNBFPKCCD-UHFFFAOYSA-N 2-hydroxy-5-octanoylbenzoic acid Chemical compound CCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 IXIGWKNBFPKCCD-UHFFFAOYSA-N 0.000 description 2
- IKRKINIKITZMKG-UHFFFAOYSA-N 2-hydroxy-5-octylbenzoic acid Chemical compound CCCCCCCCC1=CC=C(O)C(C(O)=O)=C1 IKRKINIKITZMKG-UHFFFAOYSA-N 0.000 description 2
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 2
- BANXPJUEBPWEOT-UHFFFAOYSA-N 2-methyl-Pentadecane Chemical compound CCCCCCCCCCCCCC(C)C BANXPJUEBPWEOT-UHFFFAOYSA-N 0.000 description 2
- PYSGFFTXMUWEOT-UHFFFAOYSA-N 3-(dimethylamino)propan-1-ol Chemical class CN(C)CCCO PYSGFFTXMUWEOT-UHFFFAOYSA-N 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical class NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 2
- GFOUVESKDMJIJA-UHFFFAOYSA-N 4-heptoxy-2-hydroxybenzoic acid Chemical compound CCCCCCCOC1=CC=C(C(O)=O)C(O)=C1 GFOUVESKDMJIJA-UHFFFAOYSA-N 0.000 description 2
- VHDBCRXSHLVFGR-UHFFFAOYSA-N 5-decanoyl-2-hydroxybenzoic acid Chemical compound CCCCCCCCCC(=O)C1=CC=C(O)C(C(O)=O)=C1 VHDBCRXSHLVFGR-UHFFFAOYSA-N 0.000 description 2
- DTRNDEHJGFRYBJ-UHFFFAOYSA-N 5-heptoxy-2-hydroxybenzoic acid Chemical compound CCCCCCCOC1=CC=C(O)C(C(O)=O)=C1 DTRNDEHJGFRYBJ-UHFFFAOYSA-N 0.000 description 2
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 2
- OWYWGLHRNBIFJP-UHFFFAOYSA-N Ipazine Chemical compound CCN(CC)C1=NC(Cl)=NC(NC(C)C)=N1 OWYWGLHRNBIFJP-UHFFFAOYSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 241000981595 Zoysia japonica Species 0.000 description 2
- IJCWFDPJFXGQBN-RYNSOKOISA-N [(2R)-2-[(2R,3R,4S)-4-hydroxy-3-octadecanoyloxyoxolan-2-yl]-2-octadecanoyloxyethyl] octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](OC(=O)CCCCCCCCCCCCCCCCC)[C@H]1OC[C@H](O)[C@H]1OC(=O)CCCCCCCCCCCCCCCCC IJCWFDPJFXGQBN-RYNSOKOISA-N 0.000 description 2
- -1 [(4,6-dianilino-1,3,5-triazin-2-yl) amino]- Chemical class 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 150000004347 all-trans-retinol derivatives Chemical class 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- 229940058303 antinematodal benzimidazole derivative Drugs 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000003785 benzimidazolyl group Chemical class N1=C(NC2=C1C=CC=C2)* 0.000 description 2
- 150000008366 benzophenones Chemical class 0.000 description 2
- 150000001277 beta hydroxy acids Chemical class 0.000 description 2
- 239000007957 coemulsifier Substances 0.000 description 2
- 238000005562 fading Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 239000000499 gel Substances 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 150000001261 hydroxy acids Chemical class 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 229910044991 metal oxide Inorganic materials 0.000 description 2
- 150000004706 metal oxides Chemical class 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 2
- 230000002207 retinal effect Effects 0.000 description 2
- NCYCYZXNIZJOKI-OVSJKPMPSA-N retinal group Chemical group C\C(=C/C=O)\C=C\C=C(\C=C\C1=C(CCCC1(C)C)C)/C NCYCYZXNIZJOKI-OVSJKPMPSA-N 0.000 description 2
- 229930002330 retinoic acid Natural products 0.000 description 2
- 229960003471 retinol Drugs 0.000 description 2
- 235000020944 retinol Nutrition 0.000 description 2
- 239000011607 retinol Substances 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 235000011078 sorbitan tristearate Nutrition 0.000 description 2
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical class C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- BMLMGCPTLHPWPY-REOHCLBHSA-N (4R)-2-oxo-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSC(=O)N1 BMLMGCPTLHPWPY-REOHCLBHSA-N 0.000 description 1
- BCMCBBGGLRIHSE-UHFFFAOYSA-N 1,3-benzoxazole Chemical class C1=CC=C2OC=NC2=C1 BCMCBBGGLRIHSE-UHFFFAOYSA-N 0.000 description 1
- SLPPBRLLAWJEIM-UHFFFAOYSA-N 1-ethyl-3-(4-hydroxyphenyl)urea Chemical compound CCNC(=O)NC1=CC=C(O)C=C1 SLPPBRLLAWJEIM-UHFFFAOYSA-N 0.000 description 1
- 229940043268 2,2,4,4,6,8,8-heptamethylnonane Drugs 0.000 description 1
- XHZPRMZZQOIPDS-UHFFFAOYSA-N 2-Methyl-2-[(1-oxo-2-propenyl)amino]-1-propanesulfonic acid Chemical compound OS(=O)(=O)CC(C)(C)NC(=O)C=C XHZPRMZZQOIPDS-UHFFFAOYSA-N 0.000 description 1
- SFAAOBGYWOUHLU-UHFFFAOYSA-N 2-ethylhexyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(CC)CCCC SFAAOBGYWOUHLU-UHFFFAOYSA-N 0.000 description 1
- LKVFCSWBKOVHAH-UHFFFAOYSA-N 4-Ethoxyphenol Chemical compound CCOC1=CC=C(O)C=C1 LKVFCSWBKOVHAH-UHFFFAOYSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- PGAUMPHLRWUWEN-UHFFFAOYSA-N C(=O)=C1C(C=CC(=C1)N)O Chemical compound C(=O)=C1C(C=CC(=C1)N)O PGAUMPHLRWUWEN-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- 229920002701 Polyoxyl 40 Stearate Polymers 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 208000006981 Skin Abnormalities Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000012754 barrier agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 238000005282 brightening Methods 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 229910000420 cerium oxide Inorganic materials 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 150000001893 coumarin derivatives Chemical class 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003013 cytotoxicity Effects 0.000 description 1
- 231100000135 cytotoxicity Toxicity 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- NZZIMKJIVMHWJC-UHFFFAOYSA-N dibenzoylmethane Chemical class C=1C=CC=CC=1C(=O)CC(=O)C1=CC=CC=C1 NZZIMKJIVMHWJC-UHFFFAOYSA-N 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- BECNKUVYBNETOM-UHFFFAOYSA-N ethyl n-(4-hydroxyphenyl)carbamate Chemical compound CCOC(=O)NC1=CC=C(O)C=C1 BECNKUVYBNETOM-UHFFFAOYSA-N 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 239000006081 fluorescent whitening agent Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- 150000002460 imidazoles Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940079865 intestinal antiinfectives imidazole derivative Drugs 0.000 description 1
- KUVMKLCGXIYSNH-UHFFFAOYSA-N isopentadecane Natural products CCCCCCCCCCCCC(C)C KUVMKLCGXIYSNH-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 210000002752 melanocyte Anatomy 0.000 description 1
- 229940044591 methyl glucose dioleate Drugs 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000003094 microcapsule Substances 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940100460 peg-100 stearate Drugs 0.000 description 1
- 229940032067 peg-20 stearate Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 239000011164 primary particle Substances 0.000 description 1
- 239000011252 protective cream Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000003531 protein hydrolysate Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 150000003870 salicylic acids Chemical class 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000001589 sorbitan tristearate Substances 0.000 description 1
- 229960004129 sorbitan tristearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 150000003918 triazines Chemical class 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000003313 weakening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/31—Hydrocarbons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/362—Polycarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
- A61K8/466—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur containing sulfonic acid derivatives; Salts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4966—Triazines or their condensed derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/676—Ascorbic acid, i.e. vitamin C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/42—Colour properties
- A61K2800/43—Pigments; Dyes
- A61K2800/434—Luminescent, Fluorescent; Optical brighteners; Photosensitizers
Abstract
Description
Claims (37)
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물을 포함하는 피부 미백용 조성물.
- 제 1 항에 있어서, 조성물이 피부의 즉각적인 미백을 목적으로 하는조성물.
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물을 포함하는, 안색에 균일성, 균등질성, 투명성 및 희고 보드라운 느낌중 하나 이상의 성질을 제공하는 조성물.
- 제 1 항 내지 제 3 항 중 어느 한 항에 있어서, 조성물이아시아인의 피부 보호를 위한 것을 특징으로 하는조성물.
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물을 포함하는 컨실러(concealer) 조성물.
- 제 5 항에 있어서, 백인의 피부 보호를 위한 것을 특징으로 하는조성물.
- 삭제
- 삭제
- 삭제
- 순백, 균일성, 균등질성, 투명성 및 희고 보드라운 느낌에서 선택된 하나 이상의 성질을 피부에 제공하기 위한 제제로서소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물을 포함하는 조성물.
- 제 10 항에 있어서, 광 미백제가 피부의 즉각적인 미백을 위한 제제인 것을 특징으로 하는조성물.
- 제 1 항 또는 제 2 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.1 내지 15% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물 및 상기 광 미백제계열에 속하지 않는 제 2 피부 미백제를 함유하는 것을 특징으로 하는피부 미백용조성물.
- 제 13 항에 있어서, 제 2 피부 미백제가 하이드로퀴논 및 그의 유도체, 코즈산 및 그의 유도체, 락트산 및 그의 염, 아스코르브산 및 그의 유도체, 아젤라산, 알부틴 및 그의 유도체, L-2-옥소티아졸리딘-4-카르복실산, 파라세타몰, 및 카르바메이트, 우레아 또는 술폰아미드 관능기를 갖는 하기 화학식 (1) 의 아미노페놀 유도체로부터 선택되는 것을 특징으로 하는 조성물:[화학식 1][식중, R 은 수소 원자 또는 라디칼 -COR2를 나타내고 (R2는 동일하거나 상이한 수 있으며, 히드록실화될 수 있는, 포화 또는 불포화, 선형, 고리형 또는 분지형의 C1-30알킬 또는 알콕시 라디칼로부터 선택된 라디칼을 나타낸다),R1은 하기의 화학식 (a), (b) 및 (c) 의 라디칼로부터 선택된다 :(a) -CO-NR3R4, (b) -C0-O-R5및 (c) -SO2-R5(식중, R3은 수소 원자 또는 히드록실화될 수 있는 선형 또는 분지형, 포화 또는 불포화 C1-6알킬 라디칼을 나타내고, R4는 수소 원자 또는 하기에서 정의될 라디칼 R5를 나타내며, R5는 포화 또는 불포화, 선형, 고리형 또는 분지형의 C1-30알킬 라디칼로부터 선택된 라디칼을 나타낸다)].
- 제 13 항 또는 제 14 항에 있어서, UV 복사선을 차단할 수 있는 1 종 이상의 제제 및/또는 박리제(desquamating agent)로부터 선택된 1 종 이상의 화합물을 더 함유하는 것을 특징으로 하는 조성물.
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물및 박리제로부터 선택된 1 종 이상의 화합물을 함유하는 것을 특징으로 하는피부 미백용조성물.
- 삭제
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물및 1 종 이상의 습윤제를 함유하는 것을 특징으로 하는피부 미백용조성물.
- 소듐 4,4'-비스[(4,6-디아닐리노-1,3,5-트리아진-2-일)아미노]스틸벤-2,2'-디술포네이트 및 2,5-티오펜디일비스(5-tert-부틸-1,3-벤족사졸)로 이루어진 군 중에서 선택되는 1종 이상의 화합물및 1 종 이상의 주름살 방지제를 함유하는 것을 특징으로 하는피부 미백용조성물.
- 제 18 항에 있어서, 눈 밑의 그늘의 방지 및/또는 처리를 목적으로 하는 것을 특징으로 하는 조성물.
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 삭제
- 제 12 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.5 내지 10% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 제 3 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.1 내지 15% 범위의 양으로 존재하는 것을 특징으로 하는 방법.
- 제 5 항 또는 제 6 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.1 내지 15% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 제 30 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.5 내지 10% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 제 31 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.5 내지 10% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 삭제
- 제 19 항에 있어서, 눈 밑의 그늘의 방지 및/또는 처리를 목적으로 하는 것을 특징으로 하는 조성물.
- 제 10 항 또는 제 11 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.1 내지 15% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
- 제 36 항에 있어서, 광 미백제가 조성물내에서 조성물의 총중량에 대해 0.5 내지 10% 범위의 양으로 존재하는 것을 특징으로 하는조성물.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9806109 | 1998-05-14 | ||
FR9806109A FR2778561B1 (fr) | 1998-05-14 | 1998-05-14 | Azurants optiques comme agents blanchissants |
Publications (2)
Publication Number | Publication Date |
---|---|
KR19990088163A KR19990088163A (ko) | 1999-12-27 |
KR100338399B1 true KR100338399B1 (ko) | 2002-05-27 |
Family
ID=9526368
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990016621A KR100338399B1 (ko) | 1998-05-14 | 1999-05-10 | 미백제로서의 광 미백제를 함유하는 피부 미백용 조성물 |
Country Status (10)
Country | Link |
---|---|
US (3) | US6203781B1 (ko) |
EP (1) | EP0962224B1 (ko) |
JP (2) | JP2000001417A (ko) |
KR (1) | KR100338399B1 (ko) |
CN (1) | CN1226993C (ko) |
BR (1) | BR9901889A (ko) |
CA (1) | CA2271275C (ko) |
DE (1) | DE69921545T2 (ko) |
ES (1) | ES2233005T3 (ko) |
FR (1) | FR2778561B1 (ko) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2778561B1 (fr) * | 1998-05-14 | 2001-04-20 | Oreal | Azurants optiques comme agents blanchissants |
FR2790953B1 (fr) * | 1999-03-19 | 2002-08-09 | Oreal | Composition a phase aqueuse continue renfermant de l'acide l-2-oxothiazolidine 4-carboxylique |
US6313181B1 (en) | 1999-05-26 | 2001-11-06 | Color Access, Inc. | Cosmetic compositions containing optical brighteners |
US6592882B2 (en) * | 1999-05-26 | 2003-07-15 | Color Access, Inc. | Cosmetic compositions containing fluorescent minerals |
FR2800612B1 (fr) * | 1999-11-10 | 2003-02-28 | Oreal | Composition, notamment cosmetique, comprenant un copolymere sur lequel est fixe au moins un azurant optique |
FR2802415B1 (fr) * | 1999-12-20 | 2002-07-19 | Oreal | Composition cosmetique comprenant le n-ethyloxycarbonyl-4- amino-phenol et l'arbutine ou ses derives et/ou l'acide ellagique ou ses derives |
FR2802416B1 (fr) | 1999-12-20 | 2002-07-19 | Oreal | Composition cosmetique comprenant un derive d'aminophenol |
FR2804866B1 (fr) | 2000-02-16 | 2002-04-19 | Oreal | Composition a base n-cholesteryloxycarbonyl-4-para- aminophenol et d'hydroquinone ou l'un de ses derives |
US6562321B2 (en) | 2000-12-20 | 2003-05-13 | Avon Products, Inc. | Compositions and methods for treating hyperpigmentation |
US20020159960A1 (en) * | 2001-02-27 | 2002-10-31 | Scancarella Neil D. | Method for improving the properties of transfer resistant lip compositions and related compositions and articles |
US6436378B1 (en) * | 2001-02-28 | 2002-08-20 | Colgate-Palmolive Company | Composition |
FR2830189B1 (fr) * | 2001-09-28 | 2004-10-01 | Oreal | Composition de teinture a effet eclaircissant pour fibres keratiniques humaines |
KR100430606B1 (ko) * | 2001-11-21 | 2004-05-10 | 주식회사 코리아나화장품 | 락트산 및 알부틴을 포함하는 미백 화장료 조성물 |
GB0202187D0 (en) * | 2002-01-31 | 2002-03-20 | Rowett Res Inst | "Inhibitors" |
US6852310B2 (en) * | 2002-08-23 | 2005-02-08 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
US20060018854A1 (en) * | 2002-10-02 | 2006-01-26 | Christophe Dumousseaux | Cosmetic compositions |
US8007772B2 (en) | 2002-10-02 | 2011-08-30 | L'oreal S.A. | Compositions to be applied to the skin and the integuments |
US7524485B2 (en) * | 2002-12-12 | 2009-04-28 | Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. | Skin lightening agents, compositions and methods |
US6875425B2 (en) * | 2002-12-12 | 2005-04-05 | Unilever Home & Personal Care Usa | Skin lightening agents, compositions and methods |
US7261744B2 (en) * | 2002-12-24 | 2007-08-28 | L'oreal S.A. | Method for dyeing or coloring human keratin materials with lightening effect using a composition comprising at least one fluorescent compound and at least one optical brightener |
US7736631B2 (en) | 2003-04-01 | 2010-06-15 | L'oreal S.A. | Cosmetic dye composition with a lightening effect for human keratin materials, comprising at least one fluorescent dye and at least one aminosilicone, and process of dyeing |
US7186278B2 (en) * | 2003-04-01 | 2007-03-06 | L'oreal S.A. | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one compound comprising an acid functional group and processes therefor |
US7195651B2 (en) * | 2003-04-01 | 2007-03-27 | L'oreal S.A. | Cosmetic composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one cationic polymer, and a dyeing process therefor |
US7208018B2 (en) * | 2003-04-01 | 2007-04-24 | L'oreal | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one associative polymer, process therefor and use thereof |
US7192454B2 (en) * | 2003-04-01 | 2007-03-20 | L'oreal S.A. | Composition for dyeing human keratin materials, comprising a fluorescent dye and a particular sequestering agent, process therefor and use thereof |
US7204860B2 (en) * | 2003-04-01 | 2007-04-17 | L'oreal | Composition for dyeing human keratin materials, comprising at least one fluorescent dye and at least one polyol, process therefor and use thereof |
FR2853231B1 (fr) * | 2003-04-01 | 2008-10-03 | Oreal | Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un agent sequestrant particulier, procede et utilisation |
US7150764B2 (en) * | 2003-04-01 | 2006-12-19 | L'oreal S.A. | Composition for dyeing a human keratin material, comprising at least one fluorescent dye and at least one insoluble conditioning agent, process thereof, use thereof, and devices thereof |
FR2853228B1 (fr) * | 2003-04-01 | 2006-07-14 | Oreal | Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un agent conditionneur insoluble, procede et utilisation |
US7198650B2 (en) * | 2003-04-01 | 2007-04-03 | L'oreal S.A. | Method of dyeing human keratin materials with a lightening effect with compositions comprising at least one fluorescent dye and at least one amphoteric or nonionic surfactant, composition thereof, process thereof, and device therefor |
US7195650B2 (en) * | 2003-04-01 | 2007-03-27 | L'oreal S.A. | Process for dyeing, with a lightening effect, human keratin fibers that have been permanently reshaped, using at least one composition comprising at least one fluorescent dye |
FR2853237B1 (fr) * | 2003-04-01 | 2006-07-14 | Oreal | Procede de coloration avec effet eclaircissant de fibres keratiniques humaines ayant subi une deformation permanente, au moyen d'une composition comprenant un colorant fluorescent |
FR2853235B1 (fr) * | 2003-04-01 | 2008-10-03 | Oreal | Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un compose particulier a fonction acide, procede et utilisation |
FR2853233B1 (fr) * | 2003-04-01 | 2007-10-05 | Oreal | Composition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et une silicone aminee, procede et utilisation |
FR2853238A1 (fr) * | 2003-04-01 | 2004-10-08 | Oreal | Cmposition de coloration pour matieres keratiniques humaines comprenant un colorant fluorescent et un polymere conditionneur polyorganosiloxane insoluble, procede et utilisation |
US7250064B2 (en) * | 2003-04-01 | 2007-07-31 | L'oreal S.A. | Dye composition comprising at least one fluorescent dye and a non-associative thickening polymer for human keratin materials, process therefor, and method thereof |
FR2853239B1 (fr) * | 2003-04-01 | 2010-01-29 | Oreal | Utilisation de compositions comprenant un colorant fluorescent et un tensioactif amphotere ou non ionique particuliers pour colorer avec un effet eclaircissant des matieres keratiniques humaines |
US20050031559A1 (en) * | 2003-07-07 | 2005-02-10 | L'oreal | Cosmetic composition for caring for and/or making up skin |
US9359585B2 (en) * | 2003-12-08 | 2016-06-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Stable nonaqueous reactive skin care and cleansing compositions having a continuous and a discontinuous phase |
FR2863889B1 (fr) * | 2003-12-22 | 2006-02-10 | Oreal | Composition cosmetique comprenant un azurant optique et un polymere demi cristallin, et procede cosmetique d'eclaicissement mettant en oeuvre cette composition |
US7846462B2 (en) | 2003-12-22 | 2010-12-07 | Unilever Home & Personal Care Usa, Division Of Conopco, Inc. | Personal care implement containing a stable reactive skin care and cleansing composition |
US7981404B2 (en) | 2004-04-08 | 2011-07-19 | L'oreal S.A. | Composition for application to the skin, to the lips, to the nails, and/or to hair |
US20050257715A1 (en) * | 2004-04-08 | 2005-11-24 | Christophe Dumousseaux | Compositions for application to the skin, to the lips, to the nails, and/or to hair |
US20050238979A1 (en) * | 2004-04-08 | 2005-10-27 | Christophe Dumousseaux | Compositions for application to the skin, to the lips, to the nails, and/or to hair |
US9649261B2 (en) | 2004-10-05 | 2017-05-16 | L'oreal | Method of applying makeup to a surface and a kit for implementing such a method |
ATE442064T1 (de) * | 2004-10-05 | 2009-09-15 | Oreal | Make-up-kit und -verfahren |
FR2876011B1 (fr) * | 2004-10-05 | 2006-12-29 | Oreal | Procede de maquillage d'un support et kit pour la mise en oeuvre de ce procede |
FR2877837B1 (fr) * | 2004-11-18 | 2007-04-06 | Oreal | Compositions cosmetiques comprenant des nanoparticules photoluminescentes et au moins une terre rare. |
FR2877838B1 (fr) * | 2004-11-18 | 2008-04-18 | Oreal | Compositions cosmetiques comprenant un compose organique fluorescent et une terre rare. |
WO2006054202A1 (en) * | 2004-11-18 | 2006-05-26 | L'oreal | Cosmetic compositions comprising photoluminescent nanoparticles and at least one rare-earth metal |
US20060275231A1 (en) * | 2005-05-10 | 2006-12-07 | L'oreal | Cosmetic composition, a packaging device and a method of application |
FR2888115B1 (fr) * | 2005-07-08 | 2013-02-15 | Oreal | Fond de teint liquide, procede de maquillage et kit pour la mise en oeuvre d'un tel procede. |
US20070025939A1 (en) * | 2005-07-29 | 2007-02-01 | L'oreal S.A. | cosmetic compositions containing hydroquinone and various sunscreen agents |
FR2889921B1 (fr) | 2005-08-30 | 2007-12-28 | Oreal | Ensemble de conditionnement et d'application comportant un dispositif magnetique. |
US7250158B1 (en) | 2006-03-30 | 2007-07-31 | Conopco, Inc. | Skin lightening agents, compositions and methods |
US7247294B1 (en) | 2006-03-30 | 2007-07-24 | Conopco, Inc. | Skin lightening agents, compositions and methods |
FR2956028B1 (fr) | 2010-02-08 | 2012-03-02 | Oreal | Composition cosmetique incluant au moins un compose fluorophore. |
FR2990852A1 (fr) * | 2012-05-24 | 2013-11-29 | Oreal | Colorant ou azurant anionique a contre ion ammonium ou phosphonium, composition de teinture les comprenant et procede de coloration des fibres keratiniques a partir de ces colorants |
FR2992197B1 (fr) | 2012-06-21 | 2014-06-27 | Oreal | Composition cosmetique comprenant des particules diffusantes non interferentielles et des particules d'aerogel, et procede cosmetique d'eclaircissement |
FR3013591B1 (fr) * | 2013-11-28 | 2019-06-14 | L'oreal | Procede cosmetique d'eclaircissement de la peau avec un azurant optique anionique |
US20160361239A1 (en) | 2015-06-12 | 2016-12-15 | L'oreal | Cosmetic composition comprising an ordered macroporous material |
US10729641B2 (en) | 2015-06-12 | 2020-08-04 | Regents Of The University Of Minnesota | Ordered macroporous materials |
EP3848444A1 (en) | 2018-08-14 | 2021-07-14 | The Procter & Gamble Company | Liquid fabric treatment compositions comprising brightener |
EP3848443A1 (en) | 2018-08-14 | 2021-07-14 | The Procter & Gamble Company | Fabric treatment compositions comprising benefit agent capsules |
EP3848442A1 (en) * | 2018-08-14 | 2021-07-14 | The Procter & Gamble Company | Fabric treatment compositions comprising benefit agent capsules |
FR3086171B1 (fr) | 2018-09-24 | 2021-03-12 | Crime Science Tech | Composition cosmetique comprenant un compose fluorescent |
WO2021190735A1 (fr) | 2020-03-24 | 2021-09-30 | Crime Science Technology | Composition cosmétique de maquillage ou de soin des matières kératiniques comprenant un composé fluorescent de la famille des 4-bora-3a,4a-diaza-s-indacènes, et/ou de la famille des beta-dicétonate de difluoroborane |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865326A (en) * | 1987-09-24 | 1989-09-12 | Acushnet Company | Optical brightners in golf ball clear coatings |
JPH05163115A (ja) * | 1991-12-16 | 1993-06-29 | Kanebo Ltd | 美白化粧料 |
JPH0769859A (ja) * | 1993-09-03 | 1995-03-14 | Shiseido Co Ltd | 皮膚外用剤 |
JPH0892053A (ja) * | 1994-09-20 | 1996-04-09 | Tsuneo Nanba | 皮膚外用剤 |
Family Cites Families (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3204636C2 (de) * | 1982-02-10 | 1985-02-21 | A.W. Faber-Castell Unternehmensverwaltung GmbH & Co, 8504 Stein | Schminke |
JPS62277316A (ja) * | 1986-05-27 | 1987-12-02 | Yoshiko Shirasu | 蛍光色顔料を使用する日焼け止めクリ−ムと製法 |
JP2502318B2 (ja) * | 1987-07-31 | 1996-05-29 | ポーラ化成工業株式会社 | 美白化粧料 |
CA2003346C (en) * | 1988-11-23 | 2000-02-15 | Luis C. Calvo | Fluorescent cosmetic compositions |
JPH03109343A (ja) * | 1989-09-25 | 1991-05-09 | Maruzen Kasei Co Ltd | 2,3′,4,5′―テトラヒドロキシスチルベンの製造法 |
JPH03157315A (ja) * | 1989-11-13 | 1991-07-05 | Masumi Tanaka | 化粧品 |
JP2805373B2 (ja) * | 1990-03-30 | 1998-09-30 | 株式会社資生堂 | 蛍光化粧料 |
JPH05117127A (ja) * | 1991-10-02 | 1993-05-14 | Shiseido Co Ltd | 蛍光化粧料 |
JPH05221845A (ja) * | 1992-02-17 | 1993-08-31 | Hisamitsu Pharmaceut Co Inc | チロシナーゼ阻害剤及びそれを用いた皮膚外用剤 |
JP3188021B2 (ja) * | 1993-03-01 | 2001-07-16 | 丸善製薬株式会社 | 皮膚化粧料 |
JP3369334B2 (ja) * | 1994-10-31 | 2003-01-20 | カネボウ株式会社 | 美白化粧料 |
US5618850A (en) * | 1995-03-09 | 1997-04-08 | Focal, Inc. | Hydroxy-acid cosmetics |
EP0738510A3 (fr) * | 1995-04-20 | 2005-12-21 | L'oreal | Utilisation d'un inhibiteur d'HMG-coenzyme A-reductase pour lutter contre le vieillissement de la peau et pour traiter l'acné. Composition comprenant au moins un inhibiteur HMG-coenzyme A reductase et au moins un actif possédant des propriétes desquamantes |
JP4390159B2 (ja) * | 1995-11-17 | 2009-12-24 | モーメンティブ・パフォーマンス・マテリアルズ・インク | 化粧品組成物の蛍光による光沢付与法 |
FR2751331A1 (fr) * | 1996-07-18 | 1998-01-23 | Oreal | Nouveau derive de l'acide kojique et son utilisation comme agent depigmentant |
US5880076A (en) * | 1997-08-04 | 1999-03-09 | Lever Brothers Company, Division Of Conopco, Inc. | Compositions comprising glycacarbamate and glycaurea compounds |
US5858997A (en) * | 1997-12-04 | 1999-01-12 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Method and composition for skin lightening |
FR2778561B1 (fr) * | 1998-05-14 | 2001-04-20 | Oreal | Azurants optiques comme agents blanchissants |
WO2000023044A1 (en) * | 1998-10-16 | 2000-04-27 | The Procter & Gamble Company | Uv protection compositions |
-
1998
- 1998-05-14 FR FR9806109A patent/FR2778561B1/fr not_active Expired - Fee Related
-
1999
- 1999-05-06 CA CA002271275A patent/CA2271275C/fr not_active Expired - Lifetime
- 1999-05-07 ES ES99401136T patent/ES2233005T3/es not_active Expired - Lifetime
- 1999-05-07 EP EP99401136A patent/EP0962224B1/fr not_active Expired - Lifetime
- 1999-05-07 DE DE69921545T patent/DE69921545T2/de not_active Expired - Lifetime
- 1999-05-10 KR KR1019990016621A patent/KR100338399B1/ko not_active IP Right Cessation
- 1999-05-12 BR BR9901889-6A patent/BR9901889A/pt not_active Application Discontinuation
- 1999-05-13 CN CNB991095170A patent/CN1226993C/zh not_active Expired - Lifetime
- 1999-05-13 JP JP11133196A patent/JP2000001417A/ja active Pending
- 1999-05-14 US US09/311,737 patent/US6203781B1/en not_active Expired - Lifetime
-
2000
- 2000-07-21 US US09/621,077 patent/US6403065B1/en not_active Expired - Lifetime
-
2001
- 2001-01-19 US US09/764,434 patent/US6488917B2/en not_active Expired - Lifetime
-
2006
- 2006-03-22 JP JP2006079546A patent/JP2006206602A/ja not_active Withdrawn
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4865326A (en) * | 1987-09-24 | 1989-09-12 | Acushnet Company | Optical brightners in golf ball clear coatings |
US4865326B1 (ko) * | 1987-09-24 | 1991-08-13 | Acushnet Co | |
JPH05163115A (ja) * | 1991-12-16 | 1993-06-29 | Kanebo Ltd | 美白化粧料 |
JPH0769859A (ja) * | 1993-09-03 | 1995-03-14 | Shiseido Co Ltd | 皮膚外用剤 |
JPH0892053A (ja) * | 1994-09-20 | 1996-04-09 | Tsuneo Nanba | 皮膚外用剤 |
Also Published As
Publication number | Publication date |
---|---|
FR2778561B1 (fr) | 2001-04-20 |
KR19990088163A (ko) | 1999-12-27 |
DE69921545D1 (de) | 2004-12-09 |
CA2271275A1 (fr) | 1999-11-14 |
US6488917B2 (en) | 2002-12-03 |
CN1240130A (zh) | 2000-01-05 |
DE69921545T2 (de) | 2005-10-27 |
ES2233005T3 (es) | 2005-06-01 |
CN1226993C (zh) | 2005-11-16 |
EP0962224A3 (fr) | 2000-01-05 |
JP2000001417A (ja) | 2000-01-07 |
EP0962224B1 (fr) | 2004-11-03 |
EP0962224A2 (fr) | 1999-12-08 |
JP2006206602A (ja) | 2006-08-10 |
US20010010812A1 (en) | 2001-08-02 |
FR2778561A1 (fr) | 1999-11-19 |
CA2271275C (fr) | 2008-07-15 |
BR9901889A (pt) | 2000-05-09 |
US6203781B1 (en) | 2001-03-20 |
US6403065B1 (en) | 2002-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR100338399B1 (ko) | 미백제로서의 광 미백제를 함유하는 피부 미백용 조성물 | |
EP1100434B9 (en) | Cosmetic compositions containing fluorescent minerals | |
JP3004206B2 (ja) | 皮膚のしみおよび/または老化を処置する組成物並びにその使用 | |
HU212705B (en) | Cosmetic preparative for protection against solar radiation and process for preparing thereof | |
CA2290400A1 (en) | Sunscreen composition | |
US5620680A (en) | Cosmetic and dermatological light protection formulations having an active content of cis-urocaninic acid | |
KR100478968B1 (ko) | 하나 이상의 광학 광택제가 결합된 공중합체를 함유하는조성물, 특히 화장용 조성물 | |
JP2845775B2 (ja) | 遮蔽剤の相乗的混合物をベースとした光保護性化粧品組成物とその使用方法 | |
CA2788030C (en) | A photostable sunscreen composition | |
JP2010510187A (ja) | 化粧品組成物 | |
JP2002167320A (ja) | レチノール及びuva照射を遮蔽可能な化合物を含む化粧用組成物 | |
KR20080104031A (ko) | 국소 조성물 및 그의 용도 | |
US20220218577A1 (en) | Cosmetic composition for blocking ultraviolet and infrared rays | |
AU730661B2 (en) | Sunscreen composition | |
HU215176B (hu) | Készítmény a bőr foltosodásának és/vagy öregedésének elhárítására és annak alkalmazása, valamint a bőr kozmetikai kezelése |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20130419 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20140421 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20150416 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20160419 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20170420 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20180417 Year of fee payment: 17 |
|
EXPY | Expiration of term |